The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
118 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,190,968 in first-year total cost, median $80,365.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-A (O1)]10
- Special Emphasis Panel[ZCA1 SRB-P (J1)]9
- Special Emphasis Panel[ZCA1 SRB-T (M2)]7
- Special Emphasis Panel[ZCA1 SRB-1 (J1)]6
- Special Emphasis Panel[ZCA1 SRB-1 (O1)]6
Most frequent institutions
- OHIO STATE UNIVERSITY5
- YALE UNIVERSITY5
- RESEARCH INST OF FOX CHASE CAN CTR4
- UNIVERSITY OF MINNESOTA4
- CASE WESTERN RESERVE UNIVERSITY3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Dietary Patterns and Cardiovascular Disease Risk in Childhood Cancer Survivors: St. Jude Lifetime Cohort1R03CA252485-01 | PARK, YIKYUNG | WASHINGTON UNIVERSITY, MO | $182,771 | ZCA1 |
| 2020 | Integrative functional characterization of genetic loci for cutaneous basal cell carcinoma1R03CA245886-01A1 | HAN, JIALI | INDIANA UNIVERSITY INDIANAPOLIS, IN | $173,523 | ZCA1 |
| 2020 | Effects of microenvironmental modulation on BH3 dependence in AML1R03CA252807-01 | RAMSEY, HALEY ELIZABETH | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $173,000 | ZCA1 |
| 2020 | Exploiting replication stress at telomeres in triple negative breast cancer1R03CA252689-01 | CHANG, SANDY S | YALE UNIVERSITY, CT | $167,500 | ZCA1 |
| 2020 | Epigenetic Regulation of Hemidesmosome Signaling in Pancreatic Cancer1R03CA241971-01A1 | LISS, ANDREW | MASSACHUSETTS GENERAL HOSPITAL, MA | $166,096 | ZCA1 |
| 2020 | Novel arginine-methylation mediated regulation of YAP1 in K-Ras mutant lung adenocarcinomas1R03CA246027-01A1 | SAHA, BISWARUP | H. LEE MOFFITT CANCER CTR & RES INST, FL | $164,700 | ZCA1 |
| 2020 | Characterizing Support and Opposition for E-cigarette Use Prevention Campaigns on Twitter1R03CA252680-01 | FENG, MIAO | NATIONAL OPINION RESEARCH CENTER, IL | $163,186 | ZCA1 |
| 2020 | HUNK Regulation of IL-41R03CA245774-01A1 | YEH, ELIZABETH S | INDIANA UNIVERSITY INDIANAPOLIS, IN | $158,500 | ZCA1 |
| 2020 | Dissecting the role of TCF7L1 in colorectal cancer1R03CA244133-01A1 | YOCHUM, GREGORY S. | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $158,320 | ZCA1 |
| 2020 | Early therapeutic monitoring of response to therapy with serial ultrasound in metastatic RCC1R03CA252776-01 | DAHL, JEREMYFAN, ALICE CHEN | STANFORD UNIVERSITY, CA | $157,700 | ZCA1 |
| 2020 | A Targeted Combination Therapy Approach for AML1R03CA246039-01A1 | BARNES, DAWN ELIZABETHGRAHAM, DOUGLAS K | EMORY UNIVERSITY, GA | $156,000 | ZCA1 |
| 2020 | Targeting ALT-Cancer1R03CA252796-01 | JARSTFER, MICHAEL B | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $155,500 | ZCA1 |
| 2020 | The impact of menthol and mint e-liquid bans on menthol cigarette smokers1R03CA252767-01 | DENLINGER-APTE, RACHEL | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $155,000 | ZCA1 |
| 2020 | Improving Population Representativeness of the Inference from Non-Probability Sample Analysis1R03CA252782-01 | LI, YAN | UNIV OF MARYLAND, COLLEGE PARK, MD | $154,500 | ZCA1 |
| 2020 | Automated Detection and Classification of Laryngeal Diseases Using Deep Neural Networks1R03CA253212-01 | BUR, ANDRES MARTIN | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $154,375 | ZCA1 |
| 2020 | Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors1R03CA245999-01A1 | NOLAN, TIMIYA S | OHIO STATE UNIVERSITY, OH | $153,789 | ZCA1 |
| 2020 | Identifying the role of air pollution in the lung and heart health outcomes of testicular cancer survivors1R03CA238957-01A1 | KIRCHHOFF, ANNE C | UNIVERSITY OF UTAH, UT | $152,500 | ZCA1 |
| 2020 | Childhood Cancer and Industrial Pollution (CHIP)1R03CA252684-01 | HECK, JULIA | UNIVERSITY OF NORTH TEXAS, TX | $149,897 | ZCA1 |
| 2020 | Prevention and Treatment of Oxaliplatin-Induced Peripheral Neuropathy1R03CA241788-01A1 | HINES, ROBERT BROOKS | UNIVERSITY OF CENTRAL FLORIDA, FL | $149,000 | ZCA1 |
| 2020 | Metabolomic profiling of retinoblastoma (MPR)1R03CA252788-01 | HECK, JULIA | UNIVERSITY OF NORTH TEXAS, TX | $148,500 | ZCA1 |
| 2020 | Deciphering the role of Sprouty2 in CRC progression, treatment and recurrence1R03CA249487-01 | KHARE, SHARAD | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $146,110 | ZCA1 |
| 2020 | Impact of P53 Mutations on Cancer Cell Iron Metabolism1R03CA241876-01A1 | MONTGOMERY, MCKALE | OKLAHOMA STATE UNIVERSITY STILLWATER, OK | $145,178 | ZCA1 |
| 2020 | Using the secondary structure (beta-sheet) of exosomal proteins for noninvasive pancreatic cancer detection1R03CA252783-01 | SUN, DALI | NORTH DAKOTA STATE UNIVERSITY, ND | $145,000 | ZCA1 |
| 2020 | Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world1R03CA245979-01A1 | ROBBINS, HILARY A. | INTERNATIONAL AGENCY FOR RES ON CANCER | $112,170 | ZCA1 |
| 2020 | Integrative Approach to Understand the Role of Diet, Physical Activity and Adiposity on Survival in Patients with Colorectal, Endometrial and Prostate Cancer1R03CA249027-01 | LEE, DONGHOON | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $97,693 | ZCA1 |
| 2020 | Breast Cancer Risk Factors and Epigenetic Age Acceleration1R03CA241956-01A1 | SCHUMACHER, FREDRICK RAYTHOMPSON, CHERYL L | CASE WESTERN RESERVE UNIVERSITY, OH | $97,517 | ZCA1 |
| 2020 | Exploring the shared genetic architecture of white blood cell variation and childhood acute lymphoblastic leukemia1R03CA245998-01 | DE SMITH, ADAM | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $97,340 | ZCA1 |
| 2020 | A Dual Quaternion Based Method for Estimating PTV Margins in Intensity-Modulated Radiotherapy1R03CA249545-01 | GE, QIAODELANGER, MARK P | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $94,375 | ZCA1 |
| 2020 | The role of cholesterol homeostasis in enzalutamide resistance1R03CA235060-01A1 | KOLENKO, VLADIMIR M | RESEARCH INST OF FOX CHASE CAN CTR, PA | $93,500 | ZCA1 |
| 2020 | Novel anti-CD70-VEGF-trap fusion antibodies as a next-generation therapeutic approach for renal cancer1R03CA246011-01 | MAKHOV, PETR B. | RESEARCH INST OF FOX CHASE CAN CTR, PA | $93,500 | ZCA1 |
| 2020 | Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors1R03CA219722-01A1 | ANAOKAR, JORDAN MOSSLERVIJAYVERGIA, NAMRATA | RESEARCH INST OF FOX CHASE CAN CTR, PA | $92,150 | ZCA1 |
| 2020 | Potential role of brachyury in HLA class I antigen processing machinery component downregulation in chordoma cells1R03CA253319-01 | FERRONE, SOLDANOSCHWAB, JOSEPH HASBROUCK | MASSACHUSETTS GENERAL HOSPITAL, MA | $89,856 | ZCA1 |
| 2020 | Novel role of CD73 in c-Met-mediated immune escape in renal cell carcinoma1R03CA230944-01A1 | BALAN, MURUGABASKAR | BOSTON CHILDREN'S HOSPITAL, MA | $88,500 | ZCA1 |
| 2020 | Neural and Cognitive Mechanisms of Attention and Memory Deficits in Cancer Survivors1R03CA249548-01 | ROOT, JAMES C | SLOAN-KETTERING INST CAN RESEARCH, NY | $88,500 | ZCA1 |
| 2020 | The Role of Tumor-Infiltrating Immune Cells and Estrogen Receptor Expression in Racial Disparities in Breast Cancer Biology.1R03CA238792-01A1 | OMILIAN, ANGELA | ROSWELL PARK CANCER INSTITUTE CORP, NY | $87,350 | ZCA1 |
| 2020 | Precision vitamin D supplementation as a novel approach to prevent lung cancer progression1R03CA249411-01 | HERSHBERGER, PAMELA A | ROSWELL PARK CANCER INSTITUTE CORP, NY | $87,350 | ZCA1 |
| 2020 | An Examination of Polytobacco Use Trajectories and Socioecological Risk Factors1R03CA245991-01 | SIMON, PATRICIA | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2020 | Brain Penetrant PARP Targeted PET Imaging Probes1R03CA249569-01 | CAI, ZHENGXIN | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2020 | Characterization of CEACAM1 as a novel therapeutic in mantle cell lymphoma1R03CA245996-01 | NGO, VU NGUYEN | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $82,280 | ZCA1 |
| 2020 | A Bayesian Meta-Analysis Approach for Estimation of Penetrance and its Application to PALB2 gene for Breast Cancer Risk1R03CA242562-01A1 | BISWAS, SWATI | UNIVERSITY OF TEXAS DALLAS, TX | $82,161 | ZCA1 |
| 2020 | Cryotherapy and Compression Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy in Breast Cancer Patients1R03CA238982-01A1 | ACCORDINO, MELISSA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $81,000 | ZCA1 |
| 2020 | Cabozentinib based combination therapy for the treatment of hepatocellular carcinoma1R03CA249236-01 | CHEN, XIN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $80,626 | ZCA1 |
| 2020 | Nucleolar signaling in cancer1R03CA246009-01 | PESTOV, DIMITRI G | ROWAN UNIVERSITY SCHOOL/OSTEOPATHIC MED, NJ | $80,500 | ZCA1 |
| 2020 | Deep learning for renal tumor characterization1R03CA249554-01 | BAI, HARRISON | RHODE ISLAND HOSPITAL, RI | $80,500 | ZCA1 |
| 2020 | Targeted disruption of estrogen receptor activation1R03CA241977-01A1 | YANG, SICHUN | CASE WESTERN RESERVE UNIVERSITY, OH | $80,375 | ZCA1 |
| 2020 | ω-3 fatty acid-derived mediators promote resolution of inflammation: Uncovering new strategies for preventing colitis-associated colon cancer1R03CA235106-01A1 | ZUO, XIANGSHENG | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2020 | Economic evaluation of strategies to address the significant cervical cancer burden in Malawi1R03CA227331-01A1 | MOUCHERAUD, CORRINA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $79,242 | ZCA1 |
| 2020 | Application of a humanized patient-derived xenograft mouse model to assess the preclinical efficacy of combined chemohyperthermia and chimeric TRAIL treatment in ovarian peritoneal carcinomatosis1R03CA245171-01 | LEE, YONG J | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $78,250 | ZCA1 |
| 2020 | m6A modification of fusion gene mRNAs1R03CA249558-01 | KIKYO, NOBUAKI | UNIVERSITY OF MINNESOTA, MN | $77,000 | ZCA1 |
| 2020 | Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival1R03CA249401-01 | NAGATHIHALLI, NAGARAJ S. | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $76,750 | ZCA1 |
| 2020 | Combinatorial Decitabine and Liposomal Ceramide for Acute Myeloid Leukemia1R03CA252825-01 | BARTH, BRIAN MICHAEL | UNIVERSITY OF NEW HAMPSHIRE, NH | $76,657 | ZCA1 |
| 2020 | A genomic locus associated with radiation resistance of oral cancer cells1R03CA249111-01 | IZUMI, TADAHIDE | UNIVERSITY OF KENTUCKY, KY | $76,500 | ZCA1 |
| 2020 | Identification of a central player in neoplastic transformation of intestinal stem cells:protocadherin 81R03CA246026-01 | VAN LANDEGHEM, LAURIANNE CHANTAL | NORTH CAROLINA STATE UNIVERSITY RALEIGH, NC | $76,000 | ZCA1 |
| 2020 | A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis1R03CA248913-01 | GUPTA, ROMI | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $74,250 | ZCA1 |
| 2020 | High-dimensional variable selection and prediction of ordinal pathological response data1R03CA245771-01 | ARCHER, KELLIE J. | OHIO STATE UNIVERSITY, OH | $74,065 | ZCA1 |
| 2020 | A novel mouse model of testicular granulosa cell tumors1R03CA235001-01A1 | LI, QINGLEI | TEXAS A&M AGRILIFE RESEARCH, TX | $72,685 | ZCA1 |
| 2020 | Immune-regulating MHC class I-like proteins and colorectal cancer risk1R03CA249461-01 | PRIZMENT, ANNA | UNIVERSITY OF MINNESOTA, MN | $71,244 | ZCA1 |
| 2020 | Next-generation anti-CD20 rituximab antibody that is engineered to be resistant to the immuno-suppressive effect mediated by the tumor-shed antigen, CA1251R03CA241784-01A1 | GRASSO, LUIGI | NAVROGEN, INC., PA | $69,000 | ZCA1 |
| 2020 | Role of MYC Acetylation in Oncogenic Transformation1R03CA249489-01 | MARTINEZ, ERNEST | UNIVERSITY OF CALIFORNIA RIVERSIDE, CA | $35,386 | ZCA1 |
| 2019 | ROLE OF THE HLA ANTIGEN PRESENTING MACHINERY (APM) IN RESISTANCE TO PD-1 AXIS BLOCKADE IN NON-SMALL CELL LUNG CANCER1R03CA219603-01A1 | FERRONE, SOLDANOSCHALPER, KURT A | YALE UNIVERSITY, CT | $100,670 | ZCA1 |
| 2019 | Profiling fatty acid uptake and activity in single tumor cells1R03CA227352-01A1 | WEI, WEIXUE, MIN | UNIVERSITY OF CALIFORNIA RIVERSIDE, CA | $95,258 | ZCA1 |
| 2019 | Enhancing Breast Cancer Clinicians' Communication about Sexual Health: A Mobile Technology-based (mLearning) Intervention1R03CA235238-01 | REESE, JENNIFER BARSKY | RESEARCH INST OF FOX CHASE CAN CTR, PA | $91,500 | ZCA1 |
| 2019 | A Pilot CHW Model to Facilitate Shared Decision Making and Lung Cancer Screening for Chinese Taxi Drivers1R03CA235215-01A1 | LENG, JENNIFER CF | SLOAN-KETTERING INST CAN RESEARCH, NY | $89,800 | ZCA1 |
| 2019 | Novel Methods for Missing Subtype Data in Colorectal Cancer1R03CA235122-01A1 | WANG, CHING-YUN | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $88,000 | ZCA1 |
| 2019 | A novel cancer syndrome in KCNQ1-deficient Syrian Golden hamsters1R03CA234201-01 | CORMIER, ROBERT TSCOTT, PATRICIA MWANG, ZHONGDE | UNIVERSITY OF MINNESOTA, MN | $87,704 | ZCA1 |
| 2019 | Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility1R03CA227044-01A1 | MARTINEZ PRADEDA, URSULA | H. LEE MOFFITT CANCER CTR & RES INST, FL | $86,000 | ZCA1 |
| 2019 | Small Molecules Modulating CBX7 Protein as Potential Anticancer Agents1R03CA238559-01 | ZAWARE, NILESH | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $84,750 | ZCA1 |
| 2019 | Integrated Cancer Modeling: A New Dimension1R03CA241699-01 | MA, SHUANGGE | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2019 | Adaptive immunotherapy of anaplastic thyroid cancer1R03CA239193-01 | FERRONE, SOLDANOPARANGI, SAREH | MASSACHUSETTS GENERAL HOSPITAL, MA | $82,311 | ZCA1 |
| 2019 | Cell specific blockade of PGE2 formation in the colon1R03CA235225-01 | ROSENBERG, DANIEL WILLIAM | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $81,625 | ZCA1 |
| 2019 | Impact of prostanoid metabolism on colon tumor development1R03CA235232-01 | NAKANISHI, MASAKO | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $81,625 | ZCA1 |
| 2019 | Liver-specific glucocorticoid action in liver cancer.1R03CA241781-01 | LU, HONG | UPSTATE MEDICAL UNIVERSITY, NY | $81,000 | ZCA1 |
| 2019 | Dose-finding designs for adoptive cell therapy trials1R03CA238966-01 | WAGES, NOLAN | UNIVERSITY OF VIRGINIA, VA | $80,750 | ZCA1 |
| 2019 | Elucidating the role of acetylation of APE1 in tumor growth and chemoresistance1R03CA235214-01A1 | BHAKAT, KISHOR K | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $80,355 | ZCA1 |
| 2019 | SerpinA6 Involvement in Prostate Cancer1R03CA230299-01A1 | SHUKLA, SANJEEV | CASE WESTERN RESERVE UNIVERSITY, OH | $80,000 | ZCA1 |
| 2019 | Mechanistic Insight on the Role of Berberine and AMPK in Hepatocellular Carcinoma1R03CA219764-01A1 | RANA, BASABI | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2019 | DDB2 is a regulator of HIF1A and EMT in HNSCC1R03CA227308-01A1 | BAGCHI, SRILATA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2019 | Validation of an Advanced Magnetic Resonance Imaging Protocol for Tracking Liver Cancer and Cirrhosis in a Transgenic Porcine Tumorigenic Platform1R03CA235109-01 | GABA, RON C | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2019 | Identifying and targeting epigenetic vulnerabilities in NOTCH1 driven leukemia1R03CA219523-01A1 | TZATSOS, ALEXANDROS | GEORGE WASHINGTON UNIVERSITY, DC | $79,750 | ZCA1 |
| 2019 | Impact of screening and diagnostic intensity on the study of prostate cancer epidemiology1R03CA226942-01A1 | GIOVANNUCCI, EDWARD | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $79,750 | ZCA1 |
| 2019 | High-fat diet-mediated activation of Src oncopathway in triple negative breast cancer1R03CA235113-01 | KAIPPARETTU, BENNY ABRAHAM | BAYLOR COLLEGE OF MEDICINE, TX | $79,250 | ZCA1 |
| 2019 | Epigenetic mechanisms of tumor formation in Beckwith-wiedemann Syndrome1R03CA230813-01A1 | ENGEL, NORA I | TEMPLE UNIV OF THE COMMONWEALTH, PA | $79,250 | ZCA1 |
| 2019 | Follow-up of Abnormal Findings on Colorectal Cancer Screening in a Federally Qualified Health Center: The Role of System-Level Clinical Care Processes1R03CA230947-01A1 | MAY, FOLASADE POPOOLA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $78,803 | ZCA1 |
| 2019 | Effect of skeletal compression on tumor growth and migration1R03CA238555-01 | YOKOTA, HIROKI | INDIANA UNIVERSITY INDIANAPOLIS, IN | $78,750 | ZCA1 |
| 2019 | Understanding the link between high-fructose intake and pancreatic cancer development1R03CA223717-01A1 | TODORIC, JELENA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $78,604 | ZCA1 |
| 2019 | 3q26 Amplified Genes as Cooperative Oncogenic Drivers of Lung Squamous Cell Carcinoma1R03CA235189-01 | JUSTILIEN, VERLINE | MAYO CLINIC JACKSONVILLE, FL | $78,250 | ZCA1 |
| 2019 | Secondary Use of Karyotype Data to Predict Outcomes in CLL1R03CA235101-01 | COOMBES, KEVIN ROBERT | OHIO STATE UNIVERSITY, OH | $78,000 | ZCA1 |
| 2019 | Targeting epigenetic remodeling factors to radiosensitize glioblastoma1R03CA227206-01A1 | VENERE, MONICA | OHIO STATE UNIVERSITY, OH | $78,000 | ZCA1 |
| 2019 | Determining the clinical significance of intraluminal tumor cells in endometrial cancer1R03CA230673-01A1 | FELIX, ASHLEY S. | OHIO STATE UNIVERSITY, OH | $78,000 | ZCA1 |
| 2019 | Advancing Treatment for Pediatric Craniopharyngioma (ATPC); in vivo Tocilizumab Measurement1R03CA235200-01 | HANKINSON, TODD C | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | ZCA1 |
| 2019 | Simulation Modeling to Assess Personalized Benefits and Harms of Extended Endocrine Therapy1R03CA230952-01A1 | CHANDLER, YOUNG | GEORGETOWN UNIVERSITY, DC | $77,750 | ZCA1 |
| 2019 | Targeting BCL-2 family-regulated cell death for HNSCC treatment1R03CA235097-01A1 | HARADA, HISASHI | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $77,625 | ZCA1 |
| 2019 | Establishing Biological Significance of Pteridine Metabolites in Progressive Breast Cancer1R03CA219337-01A1 | BURTON, CASEYMA, YINFASHI, HONGLAN | MISSOURI UNIVERSITY OF SCIENCE & TECHNOLOGY, MO | $77,500 | ZCA1 |
| 2019 | Therapeutic targeting of Wnt & Metabolism in Colon Cancer1R03CA223929-01A1 | WATERMAN, MARIAN L | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $77,250 | ZCA1 |
| 2019 | Dietary Quality Indexes and Cancer Risk: the Multiethnic Cohort Study1R03CA223890-01A1 | PARK, SONG-YI | UNIVERSITY OF HAWAII AT MANOA, HI | $77,000 | ZCA1 |
| 2019 | Mutagenic by-products of melanin synthesis1R03CA238683-01 | CASSIDY, PAMELA B. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $77,000 | ZCA1 |
| 2019 | Targeted Degradation of Oncoproteins1R03CA238781-01 | XIE, YOUMING | WAYNE STATE UNIVERSITY, MI | $77,000 | ZCA1 |
| 2019 | Regulation of hypoxic response by HIF isomerization1R03CA241879-01 | KIKYO, NOBUAKI | UNIVERSITY OF MINNESOTA, MN | $77,000 | ZCA1 |
| 2019 | Role of tumoral derived CCL2 in skeletal muscle wasting in breast cancer1R03CA227359-01A1 | CHENG, NIKKI | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $76,500 | ZCA1 |
| 2019 | Carbidopa as an inhibitor of the TrpT/ID01 functional complex: A novel immunotherapy agent1R03CA223271-01A1 | BHUTIA, YANGZOM DOMA | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $76,500 | ZCA1 |
| 2019 | Piloting Pathways, a Hope-Enhancing Intervention to Address Activity and Role Function in Metastatic Lung Cancer Patients1R03CA235171-01A1 | MCLOUTH, LAURIE | UNIVERSITY OF KENTUCKY, KY | $76,500 | ZCA1 |
| 2019 | Cyclin E1 and DNA Hypomethylation in Ovarian Cancer1R03CA224339-01A1 | KARPF, ADAM R. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $76,250 | ZCA1 |
| 2019 | New tools for studying the Myc super family in cancer1R03CA234998-01A1 | AYER, DONALD E | UNIVERSITY OF UTAH, UT | $76,250 | ZCA1 |
| 2019 | Role of ADAM12 in regulatory T cell accumulation within T11 claudin-low breast tumors1R03CA235194-01 | ZOLKIEWSKA, ANNA | KANSAS STATE UNIVERSITY, KS | $76,000 | ZCA1 |
| 2019 | Role of age-associated changes in the gut microbiome in promoting colorectal carcinogenesis1R03CA234999-01 | CROTT, JIMMY W | TUFTS UNIVERSITY BOSTON, MA | $75,500 | ZCA1 |
| 2019 | Label-free, high resolution, functional, two-photon imaging for non-invasive early cancer detection1R03CA235053-01A1 | GEORGAKOUDI, IRENE | TUFTS UNIVERSITY MEDFORD, MA | $74,955 | ZCA1 |
| 2019 | Identification of novel regulators of invadopodia formation1R03CA234693-01 | GARCIA-MATA, RAFAEL | UNIVERSITY OF TOLEDO, OH | $74,750 | ZCA1 |
| 2019 | Nuclear AXIN2 and Colorectal Cancer1R03CA233402-01A1 | YOCHUM, GREGORY S. | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $74,305 | ZCA1 |
| 2019 | A NOVEL EPIGENETIC IMMUNOTHERAPY FOR OVARIAN CANCER TREATMENT1R03CA230815-01A1 | GUPTA, ROMI | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $74,250 | ZCA1 |
| 2019 | Feasibility Trial of Home-Based Strength Training in Endometrial Cancer Survivors1R03CA230965-01A1 | CADMUSBERTRAM, LISA ANNE | UNIVERSITY OF WISCONSIN-MADISON, WI | $74,090 | ZCA1 |
| 2019 | Prevention of obesity-enhanced colorectal cancer via targeting soluble epoxide hydrolase1R03CA237795-01 | ZHANG, GUODONG | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $73,574 | ZCA1 |
| 2019 | UBXN2A represses migration and invasion of colorectal cancer cells1R03CA223935-01A1 | REZVANI, KHOSROW SAMUEL | UNIVERSITY OF SOUTH DAKOTA, SD | $73,500 | ZCA1 |
| 2019 | The initiation of exosome microRNA signaling in pancreatic cancer cells1R03CA235208-01 | DING, WEI-QUN | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $72,500 | ZCA1 |
| 2019 | Measuring Explained Variation in Survival Analysis1R03CA235363-01A1 | ZHANG, DABAO | PURDUE UNIVERSITY, IN | $71,739 | ZCA1 |
| 2019 | Development of an in vitro 3D tumor tissue engineering model for esophageal cancer1R03CA235244-01 | KANG, YUNQING | FLORIDA ATLANTIC UNIVERSITY, FL | $71,142 | ZCA1 |
| 2019 | Role of MYC Acetylation in Cancer1R03CA230843-01A1 | MARTINEZ, ERNEST | UNIVERSITY OF CALIFORNIA RIVERSIDE, CA | $70,790 | ZCA1 |
| 2019 | An eHealth Psychosocial Intervention for Caregivers of Children with Cancer1R03CA235002-01 | CANTER, KIMBERLY | NEMOURS CHILDREN'S HOSPITAL, DELAWARE, DE | $69,250 | ZCA1 |
| 2019 | Function of T follicular helper cells in anti-tumor immunity1R03CA235009-01 | NURIEVA, ROZA INSAFETDINOVNA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,976 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.